Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study


Por: Gomez-Martinez, C, Babio, N, Julvez, J, Becerra-Tomas, N, Martinez-Gonzalez, M, Corella, D, Castaner, O, Romaguera, D, Vioque, J, Alonso-Gomez, A, Warnberg, J, Martinez, J, Serra-Majem, L, Estruch, R, Tinahones, F, Lapetra, J, Pinto, X, Tur, J, Lopez-Miranda, J, Bueno-Cavanillas, A, Gaforio, J, Matia-Martin, P, Daimiel, L, Martin-Sanchez, V, Vidal, J, Vazquez, C, Ros, E, Dalsgaard, S, Sayon-Orea, C, Sorli, J, de la Torre, R, Abete, I, Tojal-Sierra, L, Baron-Lopez, F, Fernandez-Brufal, N, Konieczna, J, Garcia-Rios, A, Sacanella, E, Bernal-Lopez, M, Santos-Lozano, J, Razquin, C, Alvarez-Sala, A, Goday, A, Zulet, M, Vaquero-Luna, J, Diez-Espino, J, Cuenca-Royo, A, Fernandez-Aranda, F, Bullo, M, Salas-Salvado, J and PREDIMED-Plus Investigators

Publicada: 29 oct 2021 Ahead of Print: 29 oct 2021
Resumen:
Introduction Type 2 diabetes has been linked to greater cognitive decline, but other glycemic parameters such as prediabetes, diabetes control and treatment, and HOMA-IR and HbA(1c) diabetes-related biomarkers have shown inconsistent results. Furthermore, there is limited research assessing these relationships in short-term studies. Thus, we aimed to examine 2-year associations between baseline diabetes/glycemic status and changes in cognitive function in older participants at high risk of cardiovascular disease.

Methods We conducted a 2-year prospective cohort study (n=6,874) within the framework of the PREDIMED-Plus study. The participants (with overweight/obesity and metabolic syndrome; mean age 64.9 years; 48.5% women) completed a battery of 8 cognitive tests, and a global cognitive function Z-score (GCF) was estimated. At baseline, participants were categorized by diabetes status (no-diabetes, prediabetes, and <5 or >= 5-year diabetes duration), and also by diabetes control. Furthermore, insulin resistance (HOMA-IR) and glycated hemoglobin (HbA(1c)) levels were measured, and antidiabetic medications were recorded. Linear and logistic regression models, adjusted by potential confounders, were fitted to assess associations between glycemic status and changes in cognitive function.

Results Prediabetes status was unrelated to cognitive decline. However, compared to participants without diabetes, those with >= 5-year diabetes duration had greater reductions in GCF (beta=-0.11 (95%CI -0.16;-0.06)], as well as in processing speed and executive function measurements. Inverse associations were observed between baseline HOMA-IR and changes in GCF [beta=-0.0094 (95%CI -0.0164;-0.0023)], but also between HbA(1c) levels and changes in GCF [beta=-0.0085 (95%CI -0.0115, -0.0055)], the Mini-Mental State Examination, and other executive function tests. Poor diabetes control was inversely associated with phonologic fluency. The use of insulin treatment was inversely related to cognitive function as measured by the GCF [beta=-0.31 (95%CI -0.44, -0.18)], and other cognitive tests.

Conclusions Insulin resistance, diabetes status, longer diabetes duration, poor glycemic control, and insulin treatment were associated with worsening cognitive function changes in the short term in a population at high cardiovascular risk.



Filiaciones:
Gomez-Martinez, C:
 Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus, Spain

 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

Babio, N:
 Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus, Spain

 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Hosp St Joan Reus, Nutr Unit, Reus, Spain

Julvez, J:
 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

Becerra-Tomas, N:
 Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus, Spain

 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

Martinez-Gonzalez, M:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Prevent Med & Publ Hlth, Pamplona, Spain

 Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA

Corella, D:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Valencia, Dept Prevent Med, Valencia, Spain

Castaner, O:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp Del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain

Romaguera, D:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Hosp Son Espases, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Spain

:
 ISCIII, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Miguel Hernandez Univ, Nutr Epidemiol Unit, Alicante, Spain

 Univ Miguel Hernandez ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain

Alonso-Gomez, A:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Basque Country, Araba Univ Hosp, Bioaraba Hlth Res Inst,Euskal Herriko Unibertsita, Osakidetza Basque Hlth Serv,Univ Basque Country, Vitoria, Spain

Warnberg, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Malaga, Sch Hlth Sci, Inst Invest Biomed Malaga IBIMA, EpiPHAAN Res Grp, Malaga, Spain

Martinez, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Nutr Food Sci & Physiol, Pamplona, Spain

 Campus Excelencia Int Univ Autonoma Madrid Consej, Precis Nutr & Cardiometab Hlth Program, Cardiometab Nutr Grp, IMDEA Food, Madrid, Spain

Serra-Majem, L:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Las Palmas Gran Canaria, Ctr Hosp Univ Insular Materno Infantil CHUIMI, Res Inst Biomed & Hlth Sci IUIBS, Prevent Med Serv, Las Palmas Gran Canaria, Spain

Estruch, R:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDIBAPS, Dept Internal Med, Barcelona, Spain

Tinahones, F:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Malaga, Virgen de la Victoria Hosp, Inst Invest Biomed Malaga IBIMA, Dept Endocrinol, Malaga, Spain

Lapetra, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Dist Sanitario Atenc Primaria Sevilla, Res Unit, Dept Family Med, Seville, Spain

Pinto, X:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp Univ Bellvitge IBIDELL, Lipids & Vasc Risk Unit, Internal Med, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

Tur, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Inst Univ Invest Ciencias Salud IUNICS, Palma De Mallorca, Spain

 Hlth Res Inst Balearic Isl IdkSBa, Palma De Mallorca, Spain

Lopez-Miranda, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med, Cordoba, Spain

Bueno-Cavanillas, A:
 ISCIII, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Granada, Dept Prevent Med, Granada, Spain

 Inst Invest Biosanit Ibs GRANADA, Granada, Spain

Gaforio, J:
 ISCIII, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Jaen, Inst Univ Invest Olivar & Aceites Oliva, Dept Ciencias Salud, Jaen, Spain

Matia-Martin, P:
 Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Dept Endocrinol & Nutr, Madrid, Spain

Daimiel, L:
 CEI UAM CSIC, IMDEA Food, Precis Nutr & Obes Program, Nutr Control Epigenome Grp, Madrid, Spain

Martin-Sanchez, V:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Leon, Inst Biomed IBIOMED, Leon, Spain

Vidal, J:
 ISCIII, CIBER Diabet & Enfermedades Metab CIBERDEM, Madrid, Spain

 Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Endocrinol, Barcelona, Spain

Vazquez, C:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Fdn Jimenez Diaz, Dept Endocrinol, Madrid, Spain

Ros, E:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp Clin Barcelona, Dept Endocrinol & Nutr, IDIBAPS, Lipid Clin, Barcelona, Spain

Dalsgaard, S:
 Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark

 Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark

Sayon-Orea, C:
 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Prevent Med & Publ Hlth, Pamplona, Spain

Sorli, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Valencia, Dept Prevent Med, Valencia, Spain

de la Torre, R:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp del Mar Med Res Inst IMIM, Integrated Pharmacol & Syst Neurosci Res Grp, Barcelona, Spain

 Univ Pompeu Fabra, Dept Ciencias Expt & Salud CEXS, Barcelona, Spain

Abete, I:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Nutr Food Sci & Physiol, Pamplona, Spain

Tojal-Sierra, L:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Basque Country, Araba Univ Hosp, Bioaraba Hlth Res Inst,Euskal Herriko Unibertsita, Osakidetza Basque Hlth Serv,Univ Basque Country, Vitoria, Spain

Baron-Lopez, F:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Malaga, Sch Hlth Sci, Inst Invest Biomed Malaga IBIMA, EpiPHAAN Res Grp, Malaga, Spain

Fernandez-Brufal, N:
 Ctr Salud San Fermin, Elche, Spain

Konieczna, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Hosp Son Espases, Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Spain

Garcia-Rios, A:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med, Cordoba, Spain

Sacanella, E:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi Sunyer IDIBAPS, Dept Internal Med, Barcelona, Spain

Bernal-Lopez, M:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Malaga, Reg Univ Hosp Malaga, Inst Invest Biomed Malaga IBIMA, Dept Internal Med, Malaga, Spain

Santos-Lozano, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Dist Sanitario Atenc Primaria Sevilla, Res Unit, Dept Family Med, Seville, Spain

Razquin, C:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Prevent Med & Publ Hlth, Pamplona, Spain

Alvarez-Sala, A:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Valencia, Dept Prevent Med, Valencia, Spain

Goday, A:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp Del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain

Zulet, M:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Nutr Food Sci & Physiol, Pamplona, Spain

Vaquero-Luna, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Basque Country, Araba Univ Hosp, Bioaraba Hlth Res Inst,Euskal Herriko Unibertsita, Osakidetza Basque Hlth Serv,Univ Basque Country, Vitoria, Spain

Diez-Espino, J:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Dept Prevent Med & Publ Hlth, Pamplona, Spain

 Gerencia Atenc Primaria Serv Navarro Salud Osasun, Navarra, Spain

Cuenca-Royo, A:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Hosp Del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain

Fernandez-Aranda, F:
 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Hosp Bellvitge, Dept Psychiat, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain

 Univ Barcelona, Sch Med & Hlth Sci, Dept Clin Sci, Barcelona, Spain

Bullo, M:
 Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus, Spain

 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

Salas-Salvado, J:
 Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus, Spain

 Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain

 Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid, Spain

 Univ Hosp St Joan Reus, Nutr Unit, Reus, Spain
ISSN: 16642392





Frontiers in Endocrinology
Editorial
Frontiers Media S.A., AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 12 Número:
Páginas: 754347-754347
WOS Id: 000717954600001
ID de PubMed: 34777250
imagen Green Published, gold

MÉTRICAS